
    
      This is an open, longitudinal, ambispective, single center study to describe one-year disease
      progression in patients with retinitis pigmentosa due to mutation in genes with selective
      expression in rods: rhodopsin (RHO), phosphodiesterase 6A (PDE6A) or phosphodiesterase 6B
      (PDE6B).RHO,PDE6A or PDE6B mutation.
    
  